RG
ALDR
Redmile Group’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-8,244,896
| Closed | -$155M | – | 86 |
|
|
2019
Q3 | $155M | Hold |
8,244,896
| – | – | 5.2% | 5 |
|
|
2019
Q2 | $97M | Hold |
8,244,896
| – | – | 2.75% | 9 |
|
|
2019
Q1 | $113M | Buy |
8,244,896
+1,739,130
| +27% | +$23.7M | 3.29% | 7 |
|
|
2018
Q4 | $66.7M | Hold |
6,505,766
| – | – | 2.68% | 12 |
|
|
2018
Q3 | $108M | Hold |
6,505,766
| – | – | 3.33% | 8 |
|
|
2018
Q2 | $103M | Hold |
6,505,766
| – | – | 3.49% | 7 |
|
|
2018
Q1 | $82.6M | Hold |
6,505,766
| – | – | 3.19% | 7 |
|
|
2017
Q4 | $74.5M | Buy |
6,505,766
+29,000
| +0.4% | +$332K | 3.24% | 6 |
|
|
2017
Q3 | $79.3M | Buy |
6,476,766
+4,252,955
| +191% | +$52.1M | 3.91% | 6 |
|
|
2017
Q2 | $25.5M | Buy |
2,223,811
+313,925
| +16% | +$3.59M | 1.55% | 25 |
|
|
2017
Q1 | $39.7M | Buy |
1,909,886
+989,336
| +107% | +$20.6M | 2.58% | 13 |
|
|
2016
Q4 | $19.1M | Buy |
920,550
+218,011
| +31% | +$4.53M | 1.65% | 21 |
|
|
2016
Q3 | $23M | Buy |
+702,539
| New | +$23M | 1.83% | 21 |
|